Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

February 28, 2009

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DIETARY_SUPPLEMENT

ascorbic acid

DRUG

bortezomib

DRUG

melphalan

Trial Locations (8)

11203

SUNY Downstate Medical Center, Brooklyn

30076

Atlanta Cancer Care - Roswell, Roswell

32073

Florida Oncology Associates, Orange Park

34135

Florida Cancer Specialists - Bonita Springs, Bonita Springs

90069

Oncotherapeutics, West Hollywood

92868

Hematology Oncology Medical Group of Orange County, Incorporated, Orange

93720

Hematology-Oncology Medical Group of Fresno, Incorporated, Fresno

60637-1470

University of Chicago Cancer Research Center, Chicago

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Oncotherapeutics

INDUSTRY